- Home
- ARTW vs NXL Comparison
ARTW vs NXL Comparison
Compare ARTW & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- NXL
- Stock Information
- Founded
- ARTW 1956
- NXL 2010
- Country
- ARTW United States
- NXL United States
- Employees
- ARTW N/A
- NXL N/A
- Industry
- ARTW Industrial Machinery/Components
- NXL Medical Specialities
- Sector
- ARTW Industrials
- NXL Health Care
- Exchange
- ARTW Nasdaq
- NXL Nasdaq
- Market Cap
- ARTW 8.6M
- NXL 10.0M
- IPO Year
- ARTW N/A
- NXL 2022
- Fundamental
- Price
- ARTW $1.68
- NXL $2.87
- Analyst Decision
- ARTW
- NXL Hold
- Analyst Count
- ARTW 0
- NXL 1
- Target Price
- ARTW N/A
- NXL N/A
- AVG Volume (30 Days)
- ARTW 32.5K
- NXL 377.2K
- Earning Date
- ARTW 02-11-2025
- NXL 03-26-2025
- Dividend Yield
- ARTW N/A
- NXL N/A
- EPS Growth
- ARTW 17.02
- NXL N/A
- EPS
- ARTW 0.06
- NXL N/A
- Revenue
- ARTW $24,499,371.00
- NXL $162,078.00
- Revenue This Year
- ARTW N/A
- NXL $56.86
- Revenue Next Year
- ARTW N/A
- NXL $167.44
- P/E Ratio
- ARTW $27.78
- NXL N/A
- Revenue Growth
- ARTW N/A
- NXL 26.00
- 52 Week Low
- ARTW $1.33
- NXL $0.30
- 52 Week High
- ARTW $4.15
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- ARTW 45.62
- NXL 42.81
- Support Level
- ARTW $1.61
- NXL $2.80
- Resistance Level
- ARTW $1.77
- NXL $3.54
- Average True Range (ATR)
- ARTW 0.11
- NXL 0.38
- MACD
- ARTW -0.00
- NXL -0.02
- Stochastic Oscillator
- ARTW 25.81
- NXL 14.53
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.